Login / Signup

(Cost-)effectiveness of an individualised risk prediction tool (PERSARC) on patient's knowledge and decisional conflict among soft-tissue sarcomas patients: protocol for a parallel cluster randomised trial (the VALUE-PERSARC study).

Anouk A KruiswijkMichiel A J van de SandeRick L HaasM Elske van den Akker-van MarleEllen G EngelhardtPerla J Marang-van de MheenLeti van Bodegom-Vosnull null
Published in: BMJ open (2023)
NL9160, NCT05741944.
Keyphrases
  • end stage renal disease
  • soft tissue
  • ejection fraction
  • newly diagnosed
  • healthcare
  • chronic kidney disease
  • prognostic factors
  • study protocol
  • high grade
  • open label
  • patient reported outcomes